US President Trump’s 100% tariff on pharmaceutical products targets only branded and patented drugs, leaving India’s generic exports largel...

US President Donald Trump announced 100% tariffs on patented and branded drug imports. Indian generic drug makers face no immediate disrupt...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma treatment. Astr...

India is striving to reduce its dependency on China for pharmaceutical raw materials by promoting domestic production through a Production-...

Some of these PE-owned platform companies include Advent International-led Cohance Lifesciences / Suven Pharma, PAG and CX Partners-funded ...

India is called the 'pharmacy of the world' because it makes and exports drugs worth millions of dollars to many countries. But recent inci...

The companies in the thick of it are Roche, a $51 billion Swiss pharma major, and Biocon, the Bengaluru-based company led by India’s first ...

Buy Biocon Ltd. at a price target of Rs 1234.0 and a stoploss at Rs 1107.0 from entry point

As many as 12 persons with special knowledge or practical experience on matters like literature, science, art and social service are nomina...

Suresh has over 30 years of experience in the pharmaceuticals market, having worked in India and Thailand for MNCs such as GlaxoSmithKline,...

The ministry has now asked the Chinmaya Mission authorities to ensure compliance with the new regulations to be eligible for the deemed uni...

According to an audited retail sales data, all except two of the top 25 brands were launched prior to 2000 and some as early as the seventi...

Olympus Capital has invested $100m in Raman Roy’s Quatrro BPO Solutions for a “significant minority stake” in the company.